✦ LIBER ✦

Potent, orally bioavailable HIV-1 protease inhibitors containing noncoded D-amino acids

✍ Scribed by John E. Munroe; Timothy A. Shepherd; Louis N. Jungheim; William J. Hornback; Steve D. Hatch; Mark A. Muesing; MaryAnn Wiskerchen; Kenneth S. Su; Kristina M. Campanale; Angela J. Baxter; Joseph M. Colacino

Publisher: Elsevier Science
Year: 1995
Tongue: English
Weight: 310 KB
Volume: 5
Category: Article
ISSN: 0960-894X
DOI: 10.1016/0960-894x(95)00508-q

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

ChemInform Abstract: Viracept (Nelfinavi

ChemInform Abstract: Viracept (Nelfinavir Mesylate, AG1343): A Potent, Orally Bioavailable Inhibitor of HIV-1 Protease.

✍ S. H. REICH; ET AL. ET AL. 📂 Article 📅 2010 🏛 John Wiley and Sons ⚖ 34 KB 👁 2 views

Stereoselective synthesis of N-Boc-O-ben

Stereoselective synthesis of N-Boc-O-benzyl-(4S,5S)-5-amino-4-hydroxy-6-phenylhexanoic acid, the hydroxyethylene isosteric moiety of potent HIV-1 protease inhibitor

✍ Tk Chakraborty; Kiran Kumar Gangakhedkar 📂 Article 📅 1991 🏛 Elsevier Science 🌐 French ⚖ 152 KB

N-Boc-O-benzyl-(4S,5S)-5-amino-4-hydroxy-6-phenylhexanoic acid is synthesized in a highly stereoselective way involving, as a key step, regioselective opening of carbohydrate-based aziridine ring.